title: Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Iizuka
authors.forename: Shiho
authors.initials: S
authors.lastname: Sagara
authors.forename: Takeshi
authors.initials: T
authors.lastname: Etou
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab